SOX-14 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-SOX-14 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificitySOX-14
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, rat, mouse
Isotypen/a
Formatepitope affinity purified
Size0.1 mg
Concentrationn/a
ApplicationsELISA (EIA), Flow Cytometry (FC/FACS), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis antibody recognizes ~50 kDa of FOXA1 protein. It also reacts with human, mouse and rat. The other species are not tested. The forkhead box gene encodes a member of the forkhead class of DNA-binding proteins. These hepatocyte nuclear factors are transcriptional activators for liver-specific transcripts such as albumin and transthyretin, and they also interact with chromatin. Similar family members in mice have roles in the regulation of metabolism and in the differentiation of the pancreas and liver. FOXA1 plays an important role in breast cancer. The FOXA subfamily is composed of the transcription factors FOXA1, A2, A3. They were discovered as the regulators of hepatic genes. The sumoylation of Foxa1 is observed in several breast cance
Immunogenn/a
Other Names[SRY (sex determining region Y)-box 14], [Sox14; Sox14; Sox-14]
Gene, Accession #[SOX-14], Gene ID: 20669, NCBI: AKE31964.1
Catalog #MBS460383
Price$285
Order / More InfoSOX-14 Antibody from MYBIOSOURCE INC.
Product Specific ReferencesParviz Minoo, et al. SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domains. Nucleic Acids Research, 2007, 1 -10.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.